Clinical Trial: Safety, Tolerability, and Pharmacokinetic Parameters of Increasing Doses of Ingavirin Forte, Capsules, During Single and Subsequent Multiple Oral Administration in Healthy Volunteers

U.S., March 6 -- ClinicalTrials.gov registry received information related to the study (NCT06859333) titled 'Safety, Tolerability, and Pharmacokinetic Parameters of Increasing Doses of Ingavirin Forte, Capsules, During Single and Subsequent Multiple Oral Administration in Healthy Volunteers' on Feb. 20.

Brief Summary: The study of safety, tolerability, and pharmacokinetic parameters of various doses of the drug Ingavirin Forte, capsules, in healthy volunteers.

Study Start Date: Jan. 13

Study Type: INTERVENTIONAL

Condition: Influenza Viral Respiratory Infection

Intervention: DRUG: Combined preparation of imidazolylethylamide of pentanedioic acid and N,N'-bis-[2-(1,3-diazocyclopenta-2,4-dien-4-yl)ethyl] diamide of malonic acid, 90 mg +...